Compounds > bms204352
Page last updated: 2024-09-05

bms204352 and 5 alpha-androstane-3 beta,17 beta-diol

bms204352 has been researched along with 5 alpha-androstane-3 beta,17 beta-diol in 1 studies

Compound Research Comparison

Studies
(bms204352)		Trials
(bms204352)		Recent Studies (post-2010)
(bms204352)		Studies
(5 alpha-androstane-3 beta,17 beta-diol)		Trials
(5 alpha-androstane-3 beta,17 beta-diol)		Recent Studies (post-2010) (5 alpha-androstane-3 beta,17 beta-diol)
491121300

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chang, TK; Ensom, MH; Kiang, TK1

Reviews

1 review(s) available for bms204352 and 5 alpha-androstane-3 beta,17 beta-diol

ArticleYear
UDP-glucuronosyltransferases and clinical drug-drug interactions.
    Pharmacology & therapeutics, 2005, Volume: 106, Issue:1

    Topics: Clinical Trials as Topic; Drug Interactions; Enzyme Activation; Enzyme Induction; Glucuronides; Glucuronosyltransferase; Humans; Pharmaceutical Preparations; Pharmacogenetics; Polymorphism, Genetic

2005